Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome

Area of Science:

• Pediatric Nephrology
• Hematology
• Renal Medicine

Background:

• Hemolytic-uremic syndrome (HUS) is a severe condition primarily affecting children, characterized by hemolytic anemia, thrombocytopenia, and acute kidney injury.
• Plasma exchange is a therapeutic apheresis technique used in various medical conditions, including HUS, to remove harmful substances from the blood.
• The optimal management strategy for HUS, particularly regarding the role and efficacy of plasma exchange in older children with poor prognostic indicators, remains an area of investigation.

Purpose of the Study:

• To retrospectively evaluate the impact of plasma exchange on renal outcomes in children over 5 years of age diagnosed with hemolytic-uremic syndrome.
• To compare the long-term renal function and failure rates between HUS patients treated with plasma exchange and those who did not receive the treatment.

Main Methods:

• A retrospective study design was employed, analyzing data from pediatric patients diagnosed with HUS.
• Patient selection was restricted to individuals over 5 years of age, identified as a high-risk group for adverse renal prognosis.
• Renal function was assessed by monitoring parameters such as creatinine clearance, and the incidence of chronic renal failure (CRF) and end-stage renal failure (ESRF) was compared between treated and untreated cohorts.

Main Results:

• The overall evolution of renal function did not show a statistically significant difference between the plasma exchange-treated group and the untreated group.
• However, the incidence of chronic renal failure (defined as creatinine clearance < 60 mL/min/1.73 m2) and end-stage renal failure was exclusively observed in the cohort of untreated patients.
• This suggests a potential protective effect of plasma exchange against severe renal sequelae in this specific pediatric HUS population.

Conclusions:

• While plasma exchange did not significantly alter the immediate trajectory of renal function in children over 5 with HUS, it was associated with the absence of severe long-term renal complications.
• The findings suggest that plasma exchange may play a role in preventing the progression to chronic and end-stage renal failure in older children with HUS.
• Further prospective studies are warranted to confirm these observations and elucidate the precise mechanisms underlying the potential renal protective effects of plasma exchange in HUS.